[PLX] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
06-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -32.39%
YoY- -477.02%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 663 2,006 4,553 2,469 7,526 6,358 2,889 -62.48%
PBT -15,544 -11,294 -9,400 -15,141 -11,437 450 -59,148 -58.93%
Tax 230 75 132 916 8 3,045 2,087 -76.98%
NP -15,544 -11,294 -9,400 -15,141 -11,437 450 -59,148 -58.93%
Tax Rate - - - - - -676.67% - -
Total Cost 16,207 13,300 13,953 17,610 18,963 5,908 62,037 -59.10%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin -2,344.49 -563.01 -206.46 -613.24 -151.97 7.08 -2,047.35 9.44%
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -1.05 -0.77 -0.65 -1.08 -0.86 0.04 -4.75 -63.40%
EPS Diluted -1.05 -0.77 -0.65 -1.04 -0.86 -0.60 -4.75 -63.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.